MRD Tailored Therapy in AML: What We Have Learned So Far

Acute myeloid leukemia (AML) is a heterogeneous clonal disease associated with a dismal survival, partly due to the frequent occurrence of relapse. Many patient- and leukemia-specific characteristics, such as age, cytogenetics, mutations, and measurable residual disease (MRD) after intensive chemoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngai, Lok Lam, Kelder, Angèle, Janssen, Jeroen J. W. M., Ossenkoppele, Gert J., Cloos, Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871983/
https://www.ncbi.nlm.nih.gov/pubmed/33575214
http://dx.doi.org/10.3389/fonc.2020.603636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871983/
https://www.ncbi.nlm.nih.gov/pubmed/33575214
http://dx.doi.org/10.3389/fonc.2020.603636

Ejemplares similares